Mettler-Toledo’s Q2 earnings drop Thursday, riding a seven-percent revenue surge last quarter and beating EPS expectations—while analysts eye a modest 4.7% growth this time, matching last year’s 3.9% pace. Competitors Thermo Fisher and Medpace outperformed with 10.5% and 17.2% revenue jumps, lifting their stocks. The sector’s on a bullish streak, with Mettler’s shares up 10% in a month, trading above the $1,337 analyst target. Tech buzz aside, this is a solid test for the company’s momentum.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
